International Clinical Trial: Efficacy and safety of HIFU combined with immune checkpoint inhibitors in the treatment of platinum-resistant ovarian cancer: a prospective, single-center, single-arm clinical trial

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127229) titled 'Efficacy and safety of HIFU combined with immune checkpoint inhibitors in the treatment of platinum-resistant ovarian cancer: a prospective, single-center, single-arm clinical trial' on June 26.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Suining Central Hospital

Condition: ovarian cancer

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-11-18

Target Sample Size: Observation group:43;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300944

Published by HT Digital Content Services with permission fro...